Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Care centre goes high-tech to help sexual abuse victims

2016-11-25

Description: Colposcope Tags: Colposcope

The colposcope, donated by the Discovery Fund,
will be used during gynaecological examinations
to detect any irregularities.
Photo: Supplied

Rape is one of South Africa’s most pressing social problems. Rape levels in the country are often discussed and reported on, but it does not deter perpetrators from this behaviour. According to Africa Check, of the more than 42 000 rape cases reported in 2015, 15 790 were child rape cases.

In an effort to assist victims of sexual assault and rape, the University of the Free State (UFS) Department of Family Medicine adopted the Tshepong Thuthuzela Care Centre, under the leadership of UFS lecturer Dr Mariaan Kotze.

The Discovery Fund donated a colposcope to Tshepong Thuthuzela Care Centre, an instrument that works with the help of a bright light and which is used to examine victims of abuse. It has also become a standard of good practice in the assessment of child abuse worldwide. According to Dr Kotze, the new instrument will also be used for training health practitioners by rendering clinical forensic services to abuse victims.

Managing complex issues

The care centre works with between 80 and 120 victims of rape each month, a third of whom are children under 14 years of age. According to Dr Kotze, the management of child sexual abuse victims is more complex than with adults; as there is a higher chance of missing or over-diagnosing abnormalities. Also, she says, the examination process is often observed by a group of healthcare practitioners, an experience which is often intrusive and intimidating for the child. With the colposcope, the timeframe of the examination is shortened, and can be captured and viewed in real time, without the victim being present.

Best care for victims

The colposcope is a magnifier and light source used during gynaecological examinations. It is instrumental in providing the best care to victims of sexual abuse, and helps diagnose and assist in the treatment of cases of abuse. Its ability to capture and review images at the time of examination allows for retrospective research, and improves the ability of expert witnesses in court cases.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept